drugset / Trial / NCT00318955

Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients

NCT00318955 ↗

Phase 4 Completed 85 enrolled Pfizer Maruishi Pharmaceutical · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess efficacy and safety of dexmedetomidine at the time of extubation and after extubation, in patients requiring postoperative sedation in the ICU.

Timeline

Start
2005-11
Primary completion
2006-08
Completion
2006-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified — —
Comparator Propofol Small molecule — —

Indications

No indication recorded.